Engflag

Procosa

Quick links to important sections

Procosa

Procosa_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Procosa

Property Description
Active Ingredient Glucosamine Hydrochloride (Glucosamine HCl)
Form Tablet (Oral Route)
Pharmacological Class Nutraceutical / Dietary Supplement
Functional Class Chondroprotective Agent
Origin Vegetarian-Derived

What Type of Product is Procosa?

Procosa, manufactured by USANA Health Sciences, is classified as a multi-component Nutraceutical Product and Dietary Supplement, primarily focused on supporting joint health through its function as a Chondroprotective Agent. It is supplied as an oral Tablet and is designed for daily maintenance of aging joints and supporting the needs of athletes.

This product is an over-the-counter supplement, and its core ingredient, Glucosamine, is chemically an amino sugar that is recognized as a fundamental building block for cartilage structures. This indicates that the primary component supplies essential raw material for the body's natural joint maintenance processes. The overall purpose of Procosa is to promote and sustain joint comfort and help maintain healthy mobility.

Glucosamine HCl: Composition and Differentiation

The core active ingredient in Procosa is Glucosamine Hydrochloride (Glucosamine HCl). A key differentiating feature is the product’s use of vegetarian-sourced Glucosamine HCl, which is derived via fermentation, providing a non-shellfish alternative to the common Glucosamine sulfate form.

Procosa is a Combination Product that incorporates the proprietary InCelligence Joint-Support Complex. Beyond Glucosamine HCl, it includes the highly effective Meriva Bioavailable Curcumin Complex, Vitamin C (Ascorbic Acid), and Manganese. This sophisticated formulation strategy addresses the typical challenge of poor Curcumin bioavailability. Complexing curcumin with phospholipids enhances absorption and systemic availability. This formulation is engineered to ensure its components are effective at reaching the body's tissues.

General Purpose and High-Level Action

Procosa is designed to support the structure and cellular environment of the joints through a dual approach. It delivers the necessary amino sugar precursor to facilitate the body's natural synthesis of vital components for maintaining resilient cartilage and connective tissue. The inclusion of the high-bioavailability Curcumin and Vitamin C contributes to overall joint health by providing antioxidant activity and influencing normal cellular pathways. This combination of supplying structural material and supporting a balanced cellular environment forms the basis of Procosa's general purpose: sustaining long-term joint comfort and enhancing mobility in adults.

Regulatory References

  1. Curcumin: A Review of Its' Effects on Human Health - PMC

What side effects are possible with Procosa?

Possible Side Effects and Safety Information

General Safety Profile

Procosa is a dietary supplement containing glucosamine sulfate, curcumin (from turmeric extract), and vitamin C. When taken at recommended doses, the ingredients are generally considered safe for most healthy adults. However, side effects and interactions are possible, primarily associated with the main ingredients.

Potential Side Effects

Side effects for the individual components are typically mild and often involve gastrointestinal upset. Common reported side effects include:

  • Gastrointestinal Issues: Nausea, heartburn, diarrhea, constipation, and stomach pain.
  • Other: Headache, drowsiness, and skin reactions.

High doses of Vitamin C (above 2,000 mg/day) may increase the risk of kidney stones in some individuals, particularly those with a history of them.

Precautions and Warnings

Individuals with certain health conditions should exercise caution or avoid using this supplement:

  • Allergies: Glucosamine is often derived from the shells of shellfish (shrimp, crab, lobster). Individuals with a shellfish allergy should consult a healthcare provider.
  • Glaucoma: Glucosamine might increase pressure inside the eye.
  • Asthma: Glucosamine has been reported to potentially worsen asthma symptoms.
  • Diabetes: Although most studies show that glucosamine does not significantly affect blood sugar, monitoring is advised.
  • Pregnancy and Breast-feeding: There is insufficient reliable information on the safety of the components in these groups. Use should be avoided or undertaken with medical guidance.

Drug Interactions

The components of Procosa can interact with certain medications, which may increase the risk of side effects or reduce drug effectiveness. Consult a healthcare professional before use if taking any of the following types of medication:

Drug Class Potential Interaction
Anticoagulant / Antiplatelet Drugs (e.g., Warfarin) Glucosamine and Curcumin may increase the effects of these medications, raising the risk of bruising and bleeding.
Diabetes Medications Curcumin may lower blood sugar, potentially causing hypoglycemia when combined with anti-diabetes drugs. Glucosamine may also affect their effectiveness.
Chemotherapy Curcumin and Vitamin C, as antioxidants, may potentially decrease the effectiveness of some cancer treatments.
Hepatotoxic Drugs Curcumin, especially in highly bioavailable formulations, may increase the risk of liver damage when combined with other liver-harming medications (e.g., Methotrexate).

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for Procosa

The product name Procosa is associated with dietary supplements containing Glucosamine and Chondroitin. In the United States and other jurisdictions, these ingredients are regulated as supplements, and do not have a mandatory pharmaceutical-style overdose section (such as FDA Section 10 or EMA Section 4.9).

Overdose scope

  • Documented overdose presentations: Acute excessive intake of Glucosamine/Chondroitin may result in mild to moderate effects, primarily involving the digestive system. Symptoms noted in literature often include nausea, vomiting, abdominal pain, and diarrhea.
  • Physiological systems affected (as stated in label): Primarily the Gastrointestinal system. Population-specific notes require caution for patients with diabetes or impaired glucose tolerance due to a theoretical risk of affecting glucose metabolism.
  • Dose-related or exposure-related factors (if applicable): Toxicity is generally associated with very large, acute single ingestions far exceeding recommended intake.
  • Population-specific overdose notes (if applicable): Monitoring of blood sugar is generally advised for individuals with diabetes mellitus if taking the supplement, particularly in the event of over-ingestion.

Overdose classifications (high-level)

  • Severity classification (as defined in official documents): Not formally classified as an acute drug toxicity, but acute symptoms are typically mild and non-life-threatening.
  • Emergency-response statements (as written in official documents): In the event of suspected accidental or intentional excessive intake, immediate action is to contact a physician or Poison Control Center (or equivalent emergency service).
  • When immediate medical help is required (label-derived phrasing only): Medical help is required at once if an overdose is suspected or if severe symptoms or signs of systemic distress develop.

Resulting overdose structure

The documented management strategy for over-ingestion is generally symptomatic and supportive, as no specific regulatory-approved antidote is known or specified.

Connection to the overall overdose profile: Regulatory information defines the overdose profile primarily through the potential for gastrointestinal upset, stemming from the ingestion of large, excessive quantities. The official requirement to seek emergency medical attention is based on the general public safety principle that any suspected acute overexposure to a substance should be professionally evaluated by a healthcare provider or Poison Control Center immediately.

Therapeutic Uses of Procosa

Quick Facts

  • May be utilized to help manage symptoms associated with osteoarthritis.
  • May support the maintenance of joint function.
  • Intended to address discomfort in the knee joint related to wear and tear.

What Procosa Treats: Main Uses and Benefits

Procosa is a supplement that contains glucosamine hydrochloride, which may serve as a fundamental building block for certain compounds naturally present in joint cartilage. The supplement is primarily intended to support joint health and mobility, particularly in the context of age-related changes in the joints.

Its main utility is to aid in the management of symptoms associated with osteoarthritis, a condition characterized by the breakdown of cartilage and pain in the joints. Clinical information suggests a potential role in addressing knee joint discomfort and supporting functional capacity in individuals with this joint condition. The glucosamine component may contribute to the creation of substances that assist in the structure of cartilage, thereby supporting the maintenance of the joint's condition.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Procosa — official regulatory information

The eligibility profile for Procosa (Glucosamine HCl) is defined by official government warnings and monographs for the supplement category, rather than a formal pharmaceutical label.

Eligibility scope
Populations for whom use is allowed (as stated in label): Adults (18 years and older) and Older Adults.
Populations for whom use is contraindicated: Individuals with Glucosamine hypersensitivity or allergy; Patients concurrently using Warfarin (due to increased bleeding risk).
Populations for whom use is not recommended: Children and Adolescents (under 18) due to insufficient safety data; Pregnant and Breastfeeding women.
Condition-specific eligibility rules
Use with Caution: Advised for patients with Diabetes, Asthma, or Glaucoma. Close monitoring is required for diabetic patients due to potential blood sugar effects.
Source Caution: Glucosamine is often shellfish-derived, although this product's ingredient is vegetarian-derived.

Connection to the overall eligibility profile: Regulatory documents strictly limit use to the adult population, and establish an absolute contraindication for individuals on Warfarin therapy. Furthermore, regulatory advisories classify use for all pediatric, pregnant, and lactating populations as not recommended due to a lack of established safety data. Eligibility for standard use is restricted to individuals who do not have documented allergies to the active ingredient.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

The regulatory interaction profile for Procosa, based on its active ingredient Glucosamine Hydrochloride, is primarily defined by official regulatory warnings concerning its use with anticoagulants. The most significant interaction involves coumarin anticoagulants, such as Warfarin, where co-administration is formally associated with reports of pharmacodynamic potentiation of the drug's effect. This interaction results in an increased International Normalized Ratio (INR), which is an increase in the anticoagulant activity and a heightened risk of hemorrhage. This classified risk requires close monitoring of the INR for any individual co-administered these agents. The mechanism is often officially cited as unknown or believed to be pharmacodynamic, with no specific enzyme or transporter basis formally documented.

Specific Substance Interactions

Product Category
Anticoagulants (Warfarin, Dicumarol)
Antidiabetic Agents
Certain Chemotherapy Drugs (e.g., Doxorubicin)

Official regulatory summaries also contain cautions regarding the potential reduction in effectiveness of certain medications. This includes antidiabetic agents, where the supplement may affect glucose levels, and specific chemotherapy drugs. No specific timing requirements for separation of administration are officially documented. The overall structure of the regulatory profile is centered on the procedural constraint of intensified INR monitoring.

Mechanism of Action

Procosa modulates cellular processes in the articular cartilage and associated synovial tissue via its primary constituents: Glucosamine hydrochloride and Meriva Bioavailable Curcumin.

The glucosamine component, as an amino sugar, serves as a direct precursor for the biosynthesis of glycosaminoglycans (GAGs), including hyaluronic acid and aggrecans, which are key structural macromolecules of the extracellular matrix (ECM). This action upregulates the anabolic pathway within chondrocytes by supplying a rate-limiting substrate for proteoglycan synthesis, thereby influencing the osmotic and viscoelastic properties of the cartilage.

Curcumin operates as an inhibitor of multiple intracellular signaling pathways. Specifically, it acts on the activation of the Nuclear Factor kappa B (NF-κB) transcription factor, which is central to regulating the expression of pro-catabolic and pro-inflammatory mediators. By attenuating NF-κB activity, curcumin modulates the downstream expression of catabolic enzymes such as Matrix Metalloproteinases (MMPs) and Aggrecanases. Furthermore, the formulation's constituents are posited to activate autophagy, a cellular degradation pathway, to facilitate the clearance of damaged organelles and maintain cellular integrity within joint tissues. The system-level consequence of these molecular interactions is the modulation of articular tissue catabolism and the maintenance of ECM structure.

Dosage and Administration Information

How to Use Procosa: Administration Guidelines

Instructions for use define the method and schedule for taking the product. This information establishes the basis for the standardized dose and procedure for the ingredients, namely glucosamine and chondroitin sulfate.

Administration Scope

Procedural Component Guidelines
Route of Administration Oral
Dosing Schedule Three tablets per day
Administration Form Tablet

Dosing and Frequency

Administration for the key components is commonly studied at specific daily amounts. For glucosamine sulfate, a typical dose evaluated in clinical settings is 1,500 milligrams per day. For chondroitin sulfate, a dose of 1,200 milligrams per day has been widely evaluated for its safety and use.

This information provides the basis for the product's dosing protocol. The administration protocol involves taking the product in three tablets daily to meet the standardized daily intake. Specific requirements regarding timing in relation to meals or specialized preparation steps, such as dilution or shaking, are not explicitly mandated in the general administration guidelines for these compounds.

Procedural Structure

The use of Procosa is structured around the required daily intake and oral route:

  1. Take one tablet.
  2. Repeat this step two more times daily for a total of three tablets.
  3. Continue this consistent, daily intake according to the three tablets per day schedule to align with the product's conditions for use.

Connection to the Use Protocol

This procedural structure establishes the method for consuming the product, defining an oral route and a specified daily dose of three tablets. The instructions focus on ensuring the user achieves the total daily quantity of the key ingredients. Consistent adherence to this defined quantity and frequency is a fundamental aspect of the product's use.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Procosa

Evidence Overview: The Primary Focus on Osteoarthritis Symptoms

The core research available for the main ingredient in Procosa, Glucosamine Hydrochloride (Glucosamine HCl), has explored symptom patterns related to osteoarthritis (OA). This evidence is based primarily on Randomized Controlled Trials (RCTs), which are compiled in Systematic Reviews that analyze groups of these trials.

Studies monitored patient-reported outcomes describing perceived discomfort and functional balance, especially concerning the knee joint. Research involves studies applied in research contexts involving fluctuating or unstable symptoms, with typical follow-up durations ranging from 3 to 6 months. Evidence derived from these settings contributes to understanding what has been observed so far about the ingredient in conditions marked by functional limitations and associated with acute or disruptive episodes.

Trial Design and Measures of Physical Function

Researchers focused on outcomes related to physical discomfort, such as pain intensity, which was measured using standardized scales, and outcomes reflecting daily functioning or activity level. Studies explored how symptoms evolved in the observed populations, and findings describe patterns observed in the studies related to stiffness and the ease of movement.

Across different research settings, studies exploring these functional measures reported mixed findings and high variability in measured changes. Research highlights changes measured during the study period, but research does not determine whether an individual will respond similarly. Findings help contextualize how patients reported their experience and contribute to the broader evidence landscape, particularly for conditions where symptoms may vary in intensity.

Differentiating Glucosamine Forms in Research

The scientific literature notes that the available evidence is not uniform across all forms of glucosamine. The Glucosamine HCl form, which is found in Procosa, was evaluated in some trials, but the scientific literature notes that glucosamine sulfate was associated with patterns related to symptom and structural measures that were more consistently reported with the sulfate form in certain research.

Because of this difference, certainty remains low when drawing conclusions about structural measures for the Glucosamine HCl form based solely on the sulfate research. Furthermore, comparative evidence is lacking specifically for the combination of Glucosamine HCl with the bioavailable Curcumin and Vitamins found in this proprietary formula. The existing evidence base focuses mainly on the glucosamine component in isolation.

Summary of Research Gaps and Uncertainties

Evidence quality varies across studies, and data show patterns related to symptomatic outcomes for the Glucosamine HCl form were mixed. Research is ongoing, but current evidence suggests that measured changes, where observed, were often limited in magnitude. Follow-up durations were limited in many symptomatic trials, and there is limited information for long-term outcomes, particularly regarding the HCl formulation. Subgroup findings are uncertain, and data for certain groups remain insufficient.

Key Studies & References

  1. Osteoarthritis: care and management (NICE Guideline CG177)
  2. Glucosamine and Chondroitin Sulfate (NIH MedlinePlus Monograph)

Frequently Asked Questions (FAQ)

Common questions about Procosa (FAQ)

Q: Is Procosa safe to take every day for a long time?

A: Studies and official information indicate that Glucosamine HCl, the primary component, is considered 'possibly safe' for most adults when used consistently for up to two years. Safety data for use extending beyond this timeframe is not as well-established in official monographs. Individuals should discuss use beyond this timeframe with a healthcare provider.

Q: How long does it usually take to notice the benefits of Procosa?

A: Clinical information suggests that the effects of Glucosamine may not be immediate. It can typically take between four to eight weeks of consistent use before noticeable changes may be observed. Consistent use according to product guidelines is generally necessary during this initial timeframe.

Q: Are there any common mild side effects people report when starting Procosa?

A: Common, mild side effects reported for Glucosamine are usually related to the digestive system. These can include stomach pain, nausea, heartburn, diarrhea, or constipation. Other general side effects such as a headache or feeling drowsy have also been noted.

Q: What are the signs of an allergic reaction to Procosa?

A: Signs of a serious allergic reaction can include hives, significant difficulty breathing, or swelling of the face, lips, tongue, or throat. Seek immediate medical attention if these occur. The product warnings note a risk for individuals with Glucosamine hypersensitivity.

Q: Will Procosa cause stomach upset or digestive issues?

A: The Glucosamine component of the supplement has been associated with common gastrointestinal side effects. These include nausea, heartburn, diarrhea, constipation, and general stomach discomfort. Taking the product with food is sometimes recommended to help minimize gastrointestinal side effects.

Q: Is Procosa the same as chondroitin?

A: No, Procosa is not the same as Chondroitin. Glucosamine and Chondroitin are two different naturally occurring substances that serve as building blocks for cartilage. While they are often studied and used together, they are distinct compounds.

Q: Is Procosa backed by clinical studies or just anecdotal evidence?

A: Official information confirms that clinical trials have been conducted on the main components of Procosa. Studies, including those funded by the NIH, explore the use of Glucosamine for joint symptoms. However, findings regarding the effectiveness of the Glucosamine HCl form in this product have been mixed.

Q: Does Procosa need to be taken with food for better absorption?

A: While the official administration guidelines do not explicitly mandate taking the product with meals, some Glucosamine products recommend taking the dose with food. This practice may help to improve absorption and can also reduce the risk of digestive side effects like stomach upset.

Q: Where can I find research papers about Procosa's effectiveness?

A: Summaries of the research and clinical trials for Glucosamine and Curcumin are available through authoritative government-run databases. These resources include the National Institutes of Health ( NIH), MedlinePlus, and the PubMed Central research archive.

Q: Is it normal to feel a slight headache when first taking Procosa?

A: A headache is listed in official documents as one of the potential side effects associated with the use of Glucosamine. While this symptom may be temporary, any new or persistent headache is typically reported to a healthcare provider for review.

Q: How is Procosa thought to maintain cartilage?

A: The Glucosamine component in the supplement is an amino sugar that serves as a fundamental building block. The body uses these building blocks to produce key components of cartilage, which is necessary for maintaining healthy joint structure and lubrication.

Q: Can I crush or chew Procosa tablets if they are hard to swallow?

A: Unless the product's packaging explicitly states that the tablets can be altered, they should be swallowed whole. Crushing or chewing the tablet may change how the body absorbs the active ingredients, potentially affecting its intended action.

Q: Has anyone reported feeling dizzy after taking Procosa?

A: Official safety profiles for Glucosamine list 'drowsiness' as a potential side effect. Caution is advised when engaging in activities that require full mental alertness if the product causes drowsiness.

Q: Is it okay if I occasionally miss a day of taking Procosa?

A: General guidance for dietary supplements suggests that if a daily dose is missed, the general practice is to resume the regular schedule and avoid taking a double dose to compensate. Specific guidance for missed doses is typically found on the product label.

Q: What are the long-term effects of taking Procosa?

A: Safety data on Glucosamine HCl from clinical research currently extends up to about two years of use. Information regarding effects or safety beyond this two-year timeframe is limited, and long-term effects are subject to ongoing study.

Q: What evidence supports the use of Procosa for improving mobility?

A: Clinical trials have included measures of physical function and ease of movement in patients with osteoarthritis. While these studies explore symptoms, the reported outcomes on improving mobility have been mixed, and no definitive or consistent conclusion on improvement is stated.

Q: Can Procosa help with joint discomfort in the fingers or hands?

A: Most clinical research on Glucosamine has primarily focused on its effects on the knee joint. While the product may be used for general joint support, more specific study is needed to fully confirm the benefits for osteoarthritis symptoms in smaller joints like the fingers or hands.

Q: Does Procosa interact with alcohol?

A: There is no formal major interaction between the components of Procosa and alcohol. Individuals who consume alcohol are encouraged to consult with a healthcare provider, especially since some similar liquid supplement forms may contain alcohol.

How should Procosa be stored and disposed of?

How to Store and Dispose of Procosa?

Procosa must be stored according to general governmental regulatory guidelines for stability and safety, as it is classified as an oral supplement.

Official Storage Conditions

Constraint Requirement
Temperature Store in a cool, dry location, typically not exceeding 25 C (77°F).
Container Keep the container tightly closed and protect the tablets from moisture and excessive heat.
Child Safety Mandatory to store out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Unused or expired product should first be discarded through a drug take-back program, which is the preferred disposal method. If no take-back program is available, the product must be mixed with an undesirable substance (such as used coffee grounds or dirt), sealed in a plastic bag, and placed in the household trash. Tablets must not be flushed down the toilet or poured into any drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Procosa found in:

A-Z Index: